Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chlamydia Trachomatis Infection: early-phase trial registry
A small indexed set (4 trials) with no open enrollment listed right now.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count
Chlamydia Trachomatis Infection: 4 US clinical trials tracked, none currently recruiting.
Chlamydia Trachomatis Infection is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is ActivBiotics Pharma, running 1 of these trials.
Enrollment posture brief
Registry condition chlamydia-trachomatis-infection
OPEN 0 | RECR 0% | LATE 0 | EARLY 2 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Chlamydia Trachomatis Infection has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chlamydia Trachomatis Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chlamydia Trachomatis Infection is recruiting below its size-band peers.
0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
Rush University Medical Center
NCT05666778
Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT
Duke University
NCT02870101
A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections
Hoffmann-La Roche
NCT06369220
Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women
ActivBiotics Pharma
NCT01631201
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Chlamydia Trachomatis Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chlamydia Trachomatis Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chlamydia Trachomatis Infection page
4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Chlamydia Trachomatis Infection trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- ActivBiotics Pharma sponsors the most Chlamydia Trachomatis Infection trials on record, review their full trial history before evaluating a specific study. See ActivBiotics Pharma's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chlamydia Trachomatis Infection condition card totals 4 registered trials; most-linked intervention Nucleic acid amplification test 3 for NG and CT; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.